<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23461">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02012413</url>
  </required_header>
  <id_info>
    <org_study_id>2012/50167-6</org_study_id>
    <nct_id>NCT02012413</nct_id>
  </id_info>
  <brief_title>Effect of Pulsed Signal Therapy in Patella Chondromalacia</brief_title>
  <official_title>Effect of Pulsed Signal Therapy in Patella Chondromalacia. Randomized Prospective Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PST (pulsed signal therapy) is a unique form of pulsed electromagnetic field therapy (PEMF)
      for stimulating healing of damaged structures such as cartilage, bones and soft tissues. The
      physical effect of the pulsed electromagnetic field (PEMF) has been focus of research in
      various studies, with cartilage being the most studied, and which has demonstrated an
      increase in the synthesis of proteoglican and collagen in vitro. A T2 MAP diagram MRI is
      considered a method in evaluating the indirect biochemical quantity of articular cartilage
      which may traduce functional behavior of the articular cartilage. This is an randomized,
      control and double blind clinical trial. The  main objective is to evaluate in vivo the
      effect of PST on patella cartilage in patients with chondromalacia through the T2 MAP
      diagramed MERI technique. The secondary objective is to evaluate clinical improvement
      regarding anterior knee pain after PST intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PST is a proprietary pulsed electromagnetic field therapy protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>T2 Mapping MRI Outcome</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>T2 Mapping MRI analyses will be performed before and three-month after PST intervention.
Three consecutive slices of the T2 map; assessment of T2 values (T2 relaxation times - unit: ms)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical improvement - KOOS</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>A functional score (KOOS) and visual analog scale for pain evaluation will be performed before, at 1 month, at 3 month, at 6 month and at one year after PST intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Patella Chondromalacia</condition>
  <arm_group>
    <arm_group_label>PST group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 patients will do a pre teatment MRI, then will be treated with PST plus physiotherapy, and repeat the MRI after 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 patients will do MRI after treatment, these patients wil be treat with PST-placebo plus physiotherapy, after 3 months will do MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PST - Pulsed Signal Therapy</intervention_name>
    <description>PST application is a painless over-the-skin eletromagnetic field application. 9 sessions of application of electromagnetic therapy - PST - during 60 minutes</description>
    <arm_group_label>PST group</arm_group_label>
    <other_name>PST</other_name>
    <other_name>PEMF</other_name>
    <other_name>Pulsed Eletromagnetic Field</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo - Sham PST</intervention_name>
    <description>Placebo PST will be performed by applying the same device over the patient knee. The machine is not applying the PST but it appears to be on. In this way, patients are blinded to the intervation.
9 sessions of application of Sham PST - during 60 minutes</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with patella femoral syndrome

          -  patients without previous surgery

          -  patients without any disease in the other leg

          -  patients without contraindications for PST use

        Exclusion Criteria:

          -  pantients who abandonment the treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriana Lucia P Silva, B.Sc., M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riccardo G Gobbi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilberto L Camanho, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco K Demange, M.D. , Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University of São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tania Fernandes, B.A.</last_name>
    <phone>+55-11-976-515-344</phone>
    <email>taniafernanda@terra.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital das Clínicas - Universty of São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tania Fernandes, B.A.</last_name>
      <email>taniafernanda@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Marco K Demange, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riccardo G Gobbi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 9, 2013</lastchanged_date>
  <firstreceived_date>August 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Marco Kawamura Demange</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>knee</keyword>
  <keyword>chondromalacia</keyword>
  <keyword>patella</keyword>
  <keyword>pulsed signal therapy</keyword>
  <keyword>PST</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chondromalacia Patellae</mesh_term>
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
